Overview

Out of an abundance of caution and the measured reopening of Massachusetts in light of the COVID-19 pandemic, the 2020 Boston IBD meeting will be a virtual meeting. The planning committee has been hard at work reimagining the meeting. We are excited to present current and cutting edge content in this new format.

 

Join us on-line as follows:

Friday September 25th | 11:45 am – 4:10pm
Session 1 – Keynote Session, Lectures and Panels

Friday September 25th | 4:25 - 5:25pm
Session 2 – Small Group Meet the Professor Meetings

Saturday September 26th | 7:50 – 10:50am
Session 3 – Keynote Session, Lectures and Panels

Saturday September 26th | 11:00am – 12 noon
Session 4 – Choice of Breakout Sessions

There will be an online exhibit hall where you can connect with our longtime exhibitors.

Please see the agenda tab for more details.

 

What past attendees have said about the Boston IBD Meeting:

  • "Excellent conference! Would continue with this format. Case discussions were good."

  • "Wonderful and as always highly educational! Provides useful information we can apply to our practice daily."


The goal of the conference is to initiate practice changes in gastroenterology practices in the diagnosis and management of patients with CD and UC so as to improve quality of life for these patients while prolonging clinical remission. This meeting will provide support and enable participating clinicians to enhance their knowledge, competency, and performance in the areas of patient care, medical knowledge, and practice-based learning and improvement. 

Additionally, in the current era of COVID-19, patients with underlying medical conditions like inflammatory bowel disease might be at higher risk of severe illness from COVID-19. Given the rate that emerging science and data is transforming the clinical insight into this pandemic, there are limited gastroenterology-focused resources currently available for clinicians who treat high-risk patient groups. To help address that need, the proposed curriculum will review the ever-changing epidemiology of COVID-19 and identify primary infection risk concerns for patients with inflammatory bowel disease (IBD).

 

View All Speakers

Speakers

Randall Pellish, MD



View Full Bio

Samir Shah, MD, FACG, FASGE, AGAF



View Full Bio

Charles N. Bernstein, MD


Distinguished Professor of Medicine Director, University of Manitoba IBD Clinical and Research Centre Bingham Chair in Gastroenterology University of Manitoba
View Full Bio

Joel Weinstock, MD



View Full Bio

Beth-Ann Norton, MS, RN, ANP-BC


Nursing Program Director Crohn's and Colitis Center Brigham and Women’s Hospital
View Full Bio

Michael J. Callahan, MD



View Full Bio

Robert Burakoff, MD, MPH, FACG, AGAF



View Full Bio

D. Punyanganie DeSilva, MBBS, MPH, MRCP(UK)



View Full Bio

Lori Zimmerman, MD



View Full Bio

Francis Farraye, MD, Msc, FACG



View Full Bio

Sharmeel Wasan, MD, FACG


Course Co-Director Assistant Professor of Medicine, Boston University Fellowship Program Director, Section of Gastroenterology Boston Medical Center
View Full Bio

Joseph D. Feuerstein, MD



View Full Bio

Paul A. Rufo, MD, MMSc



View Full Bio

Arpan Mohanty, MBBS



View Full Bio

Sean Fine, MD, MS



View Full Bio

Debjani Sahni, MBBS



View Full Bio

Athos Bousvaros, MD, MPH



View Full Bio

Ansu Noronha, MD


Assistant Professor Section of Gastroenterology Boston Medical Center
View Full Bio

Rachel Winter, MD, MPH



View Full Bio

Michael Kappelman, MD, MPH


Professor of Pediatrics, University of North Carolina at Chapel Hill
View Full Bio

Steven N. Fine, MD



View Full Bio

Ashwin Ananthakrishnan, MD, MPH


Associate Professor of Medicine Harvard Medical School Director, Crohn’s and Colitis Center Massachusetts General Hospital
View Full Bio

Joel Goldberg, MD, MPH, FACS



View Full Bio

Joshua Korzenik, MD



View Full Bio

Alan Moss, MD, FACG, FEBG, AGAF, FRCPI



View Full Bio

Jessica R. Allegretti, MD, MPH



View Full Bio

Daniel S. Pratt, MD, FAASLD


Clinical Director, Liver Transplantation Director, Autoimmune & Cholestatic Liver Center Massachusetts General Hospital
View Full Bio

Sonia Friedman, MD, FACG



View Full Bio

Colleen Kelly, MD, FACG



View Full Bio

Alexander Levy, MD



View Full Bio

Scott Snapper, MD, PhD



View Full Bio

Russell D. Cohen, MD, FACG, AGAF


Professor of Medicine, Pritzker School of Medicine Medical Director, Offsite Operations, Section of Gastroenterology Director, Inflammatory Bowel Disease Center Co-Director, Advanced IBD Fellowship Program The University of Chicago Medicine
View Full Bio

Jess Kaplan, MD


Pediatric Gastroenterologist Clinic Director, Pediatric Inflammatory Bowel Disease Program MassGeneral Hospital for Children Assistant Professor of Pediatrics Harvard Medical School
View Full Bio

Kathleen Viveiros, MD



View Full Bio

Accreditation

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Boston University School of Medicine designates this live activity for a maximum of 9 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.75 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participantswill earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn 6.75 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.*

By attending this activity and providing your ABIM or ABP number and Date of Birth, you authorize BUSM CME office to report your information to the ACCME so that we may process your MOC Part II credit on your behalf.

The Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 12.5 hours of Category I credits™ for completing this program.

The program has been submitted to ABCGN for GI-specific approval.

 

Acknowledgement

Education program is endorsed by:

 

Education program is provided by:

  • Boston University School of Medicine | Continuing Medical Education

 

In conjunction with:

  • Boston Medical Center
  • Beth Israel Deaconess Medical Center
  • Brigham and Women’s Hospital
  • Boston Children’s Hospital
  • Lahey Hospital & Medical Center
  • Massachusetts General Hospital
  • Tufts Medical Center
  • UMass Memorial Medical Center